ArticleBMC gastroenterology2026
Short‑ and long‑term prognostic factors of non‑neoplastic esophageal fistula: a retrospective study of 100 patients.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeThis study examines the effects of different treatments on the prognosis of non-malignant esophageal fistula, a rare but serious condition, and identifies factors affecting post-fistula survival and healing.
methodsThis study retrospectively analyzed clinical data of patients with non-malignant esophageal fistula, categorizing them into conservative, endoscopic, and surgical groups. It compared Clinical Pulmonary Infection Score (CPIS) gap, hospital stay length, ICU admission, 30-day readmission, in-hospital and 90-day mortality rates, and hospitalization costs among these groups, while also assessing factors influencing post-fistula survival and healing.
results100 patients were included. Those who had surgery experienced longer hospital stays (P < 0.001), higher ICU occupancy rates (P = 0.006), and increased costs (P = 0.001) compared to others. Patients treated conservatively had a higher 30-day readmission rate (P = 0.018). Post-fistula survival and healing were unaffected by the primary treatment approach. Multivariate Cox regression indicated that smaller fistulas (P = 0.048), nasojejunal tube (P = 0.045), and thoracic drainage tube (P = 0.035) were favorable factors for fistula healing, while a lower BMI (P = 0.026) negatively impacted post-fistula survival.
conclusionEndoscopic treatment showed better short-term outcomes than the other groups, though it didn’t significantly improve post-fistula survival and healing. Several factors significantly impact the prognosis of esophageal fistula patients, requiring careful consideration in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.